MAP2K1 and cardiac hypertrophy: GA significantly ameliorated cardiac function and inhibited cardiac hypertrophy and fibrosis by disruption of PI3K–Akt–GSK3β and MEK1/2–ERK1/2– GATA4 signaling and via Ang II stimulation (Wang et al., 2013; Wang et al., 2019).